Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2000
06/14/2000EP1007505A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007080A1 Sustained peptide-release formulation
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP1007002A1 Lipid-containing compositions and uses thereof
06/13/2000US6075032 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000CA2146127C Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032578A1 Benzimidazole compounds that are vitronectin receptor antagonists
06/08/2000WO2000032228A2 Peptide-based vaccine for influenza
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments
06/08/2000WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
06/08/2000WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352454A1 Peptide-based vaccine for influenza
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005369A2 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/07/2000EP1005358A1 Method for preventing and treating hearing loss using a neurturin protein product
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1255362A Exterior-applied Chinese patent medicine for treating tympanitis
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071924 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
06/06/2000US6071904 Process for manufacturing ophthalmic suspensions
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000CA2206233C Combination dosage form comprising cetirizine and pseudoephedrine
06/06/2000CA2130988C Pharmaceutical composition for treatment of sudden deafness
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000WO2000031080A1 [pyrrole]naphthopyranes, their preparation, compositions and (co)polymer matrices containing them
06/02/2000WO2000031070A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031048A1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
06/02/2000WO2000031046A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000030651A1 Use of staurosporine derivatives for treating ocular neovascular diseases
06/02/2000WO2000030613A1 New process
06/02/2000WO2000018388A3 Antibiotic compositions for treatment of the eye, ear and nose
06/02/2000WO2000009105A3 Small molecule carbamates or ureas for vision and memory disorders
06/02/2000CA2352477A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351630A1 Vector
06/02/2000CA2349721A1 N-¬4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl|-acrylamide, an irreversible inhibitor of tyrosine kinases
05/2000
05/31/2000EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
05/31/2000EP1004307A2 Ophthalmic composition
05/31/2000EP1003739A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
05/31/2000EP1003729A1 6-azauracil derivatives as il-5 inhibitors
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003555A1 Controlled release of ophthalmic compositions
05/31/2000EP1003553A1 The use of angiostatic steroids in photodynamic therapy
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003530A1 Eye treatments using synthetic thyroid hormone compositions
05/31/2000EP1003522A1 A method for preventing or controlling cataract
05/31/2000EP1003505A1 Heterocyclic vinylethers against neurological disorders
05/31/2000EP1003479A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases
05/31/2000EP1003474A1 Method of treating dry eye disease with purinergic receptor agonists
05/31/2000EP1003374A4 Inhibitors of farnesyl-protein transferase
05/31/2000EP1003374A1 Inhibitors of farnesyl-protein transferase
05/31/2000DE19955340A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists
05/31/2000DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs
05/31/2000CN1255064A Use of 'alpha'-methyl-P-tyrosine to inhibit melanin production in iris melanocytes
05/30/2000US6069156 Indole derivatives as cGMP-PDE inhibitors
05/30/2000US6069139 Method and composition for prophulaxis and treatment of retinal diseases
05/30/2000US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences
05/30/2000CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals
05/25/2000WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000WO2000029447A1 Rhamm antagonist antibodies
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/25/2000WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
05/25/2000WO2000029371A1 Excitatory amino acid receptor modulators
05/25/2000WO2000028998A1 Liquid ophthalmic preparations
05/25/2000WO2000028988A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/25/2000WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives
05/25/2000WO2000021528A8 Use of ophthalmic composition comprising vitamin a and vitamin e
1 ... 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 ... 531